The ligands of NKG2D include MICA, MICB and ULBP1-6 (32, 33) and are upregulated in multiple tumor entities like acute myeloid leukemia, ovarian-, breast-, lung-cancer, melanoma, glioma and STS (17). Here, KLRK1 is linked to telomere syndrome.